Literature DB >> 16673247

[Paraurethral abscess developing after mid-urethral Zuidex-injection in women with stress urinary incontinence -- management of complications and retrospective comparison with bladder neck located injection technique].

T Hagemeier1, U Blau, A Gauruder-Burmester, R Tunn.   

Abstract

PURPOSE: To evaluate the cause and management of paraurethral abscess developing after injection of a mixture of hyaluronic acid and dextranomer (Zuidex) for treating stress urinary incontinence. PATIENTS AND
METHOD: A total of 127 women having undergone midurethral Zuidex injection and 34 women after endoscopically guided Deflux injection into the tissue around the bladder neck were followed up 1 to 24 months after the intervention. At follow-up, the paraurethral tissue was evaluated clinically by gynecologic examination and by introital ultrasound.
RESULTS: Thirteen of 127 women (10 %) having undergone midurethral Zuidex injection had a sterile paraurethral abscess that was treated by transvaginal puncture (1 to 3 punctures with removal of 10-60 ml of fluid per patient). No case of postoperative paraurethral abscess formation was demonstrated in the control group treated by Deflux injection into the area around the bladder neck.
CONCLUSIONS: Paraurethral abscess must be excluded in the postinterventional follow-up of patients after Zuidex injection. Patients in whom an abscess is demonstrated can be treated by transvaginal puncture. Abscess formation can be avoided by injecting dextranomer/hyaluronic acid into the area around the bladder neck.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673247     DOI: 10.1055/s-2006-921343

Source DB:  PubMed          Journal:  Zentralbl Gynakol        ISSN: 0044-4197


  5 in total

1.  Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI).

Authors:  Farah Lone; Abdul H Sultan; Ranee Thakar
Journal:  Int Urogynecol J       Date:  2010-06-23       Impact factor: 2.894

2.  Where should bulking agents for female urodynamic stress incontinence be injected?

Authors:  Annette Kuhn; Werner Stadlmayr; Daniela Lengsfeld; Michel D Mueller
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

3.  An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence.

Authors:  Gunnar Lose; Helle Christina Sørensen; Susanne M Axelsen; Christian Falconer; Kurt Lobodasch; Tosson Safwat
Journal:  Int Urogynecol J       Date:  2010-07-20       Impact factor: 2.894

Review 4.  Urethral bulking agents: techniques and outcomes.

Authors:  Ahmed F Kotb; Lysanne Campeau; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

5.  An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence.

Authors:  Giuseppe Dodi; Johannes Jongen; Fernando de la Portilla; Manoj Raval; Donato F Altomare; Paul-Antoine Lehur
Journal:  Gastroenterol Res Pract       Date:  2010-12-27       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.